Disc Medicine, Inc.
74.51USD
-0.5200 (-0.69%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on IRON.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | — | — | — | — | 0.0 | 32.6M |
| Q1 | — | — | — | — | — | — |
| Q2 | — | — | — | — | — | — |
| Q3 | — | — | — | — | 0.0 | — |
| Q4 | — | — | — | — | 0.0 | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -2.15 | -3.42 | -3.96 | -6.01 | -6.57 | -6.92 |
| Q1 | -.508 | -1.20 | -1.09 | -1.02 | -1.65 | — |
| Q2 | -.483 | -.740 | -1.03 | -1.58 | -1.54 | — |
| Q3 | -.801 | -.580 | -.890 | -1.77 | -1.71 | — |
| Q4 | -.515* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -1.06* |
| -1.07* |
| -1.71* |
| -1.74 |
| — |
Debt level and coverage